Shares are down nearly 80% in 2025, but Trump signed executive order to reclassify marijuana.
Incannex Healthcare reports Q1 financial results, highlights progress in clinical trials, and announces strategic financing and new CMO appointment.Quiver AI SummaryIncannex Healthcare Inc. has published...
A new survey conducted by Quantum Research Group, LLC finds that more than half of patients diagnosed with sleep apnea are not satisfied with their current treatment. Nearly 70 percent of patients express...
These stocks are coming off a banner month, but what about the road ahead?
/PRNewswire/ -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), ('Incannex' or the 'Company') a clinical-stage pharmaceutical company developing unique...
/PRNewswire/ -- Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), ('Incannex' or the 'Company'), is...
/PRNewswire/ -- Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL), ('Incannex' or the 'Company') a clinical-stage pharmaceutical company developing unique...
/PRNewswire/ -- Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL), ('Incannex' or the 'Company') a clinical-stage pharmaceutical company developing unique...
Profit-taking after a big gain earlier this week took its toll.